192 results on '"Bonaldi, Laura"'
Search Results
2. Large B-cell lymphoma with IRF4 rearrangement: a multi-centric study with focus on potential misleading phenotypes
3. Correction to: Large B-cell lymphoma with IRF4 rearrangement: a multi-centric study with focus on potential misleading phenotypes
4. Exploring the prognostic role of complex karyotype in chronic lymphocytic leukaemia patients treated with venetoclax‐based regimens
5. When Waldenström macroglobulinemia hits the kidney: Description of a case series and management of a “rare in rare” scenario
6. Impact of the presence and number of chromosomal abnormalities on the clinical outcome in Waldenström Macroglobulinemia: a monocentric experience
7. Large B-cell lymphoma with IRF4 rearrangement: a multi-centric study with focus on potential misleading phenotypes
8. Waldenström Macroglobulinemia in Very Elderly (≥75-year-old) Patients: A 33-year-retrospective Cohort Study in an Italian University Hospital
9. A case of “double hit” mantle cell lymphoma carrying CCND1 and MYC translocations relapsed/refractory to rituximab bendamustine cytarabine (R-BAC) and ibrutinib
10. Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease Course.
11. P-129 Real world evidence of prognostic impact of t(14;16) translocation in multiple myeloma: a report of the myeloma triveneto working group
12. P1111: WALDENSTRÖM MACROGLOBULINEMIA IN THE VERY ELDERLY (≥75-YEAR-OLD): DESCRIPTION OF CLINICAL FEATURES AND SURVIVAL OUTCOMES IN A CASE SERIES FROM AN ITALIAN ACADEMIC CENTER
13. The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia
14. Identification of the true hyperdiploid multiple myeloma subset by combining conventional karyotyping and FISH analysis
15. Splenic marginal zone lymphoma with a de novo t(8;14)(q24;q32) and a prolymphocytoid evolution responsive to rituximab-bendamustine
16. Supplementary Figures from Genetic, Epigenetic, and Immunologic Profiling of MMR-Deficient Relapsed Glioblastoma
17. Supplementary Methods from Genetic, Epigenetic, and Immunologic Profiling of MMR-Deficient Relapsed Glioblastoma
18. The added value of karyotype in predicting the need for therapy in chronic lymphocytic leukemia with 13q deletion
19. Cytogenetic Impact on Lenalidomide Treatment in Relapsed/Refractory Multiple Myeloma: A Real-Life Evaluation
20. Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic Leukemia
21. Necrotizing Follicular Lymphoma of the Inguinal Region with Sternbergoid Cells: Clinical–Pathological Features of a Challenging Entity
22. Sequential allogeneic transplantation and ruxolitinib maintenance for a synchronous PCM1‐JAK2 positive myeloid sarcoma and acute B‐lymphoblastic leukemia
23. Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis
24. Relevance of bone marrow histology in challenging cases of Acute Myeloid Leukemia
25. Sequential allogenic transplantation and ruxolitinib maintenance for a synchronous PCM1-JAK2 positive Myeloid Sarcoma and Acute B-Lymphoblastic Leukemia
26. DNA copy number alterations correlate with survival of esophageal adenocarcinoma patients
27. The complex karyotype landscape in chronic lymphocytic leukemia allows the refinement of the risk of Richter syndrome transformation
28. FISH analysis of chromosomes 3 and 6 on fine needle aspiration biopsy samples identifies distinct subgroups of uveal melanomas
29. In vivo monosomy 3 detection of posterior uveal melanoma: 3-year follow-up
30. Relevance of bone marrow histology in challenging cases of Acute Myeloid Leukemia.
31. Complex Karyotype Subtypes at Chronic Lymphocytic Leukemia Diagnosis Refine the Risk of Developing a Richter Syndrome. the Richter Syndrome Scoring System
32. Antiretroviral therapy and the clinical evolution of human papillomavirus-associated genital lesions in HIV-positive women
33. Correlations Between O6-Methylguanine DNA Methyltransferase Promoter Methylation Status, 1p and 19q Deletions, and Response to Temozolomide in Anaplastic and Recurrent Oligodendroglioma: A Prospective GICNO Study
34. Spontaneous evolution of essential thrombocythaemia into acute megakaryoblastic leukaemia with trisomy 8, trisomy 21 and cutaneous involvement
35. Uveal Melanoma Biopsy: A Review
36. Genetic, Epigenetic, and Immunologic Profiling of MMR-Deficient Relapsed Glioblastoma
37. Severe infections unrelated to neutropenia impact on overall survival in multiple myeloma patients: results of a single centre cohort study
38. Chronic Myeloid Leukemia With Myelofibrosis-Like Features. Clues of Accelerated Phase?
39. The Combination of Complex Karyotypes' Subtypes and IGHV Mutational Status Provides Prognostic and Predictive Information in Chronic Lymphocytic Leukemia
40. Epstein-Barr virus-associated post-transplant lympho-proliferative disease of donor origin in liver transplant recipients
41. Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalities
42. BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome
43. In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics
44. Role of miR-15a/miR-16-1 and the TP53 axis in regulating telomerase expression in chronic lymphocytic leukemia
45. Inactivation of CK1α in multiple myeloma empowers drug cytotoxicity by affecting AKT and β-catenin survival signaling pathways
46. Evaluation of Integrated CLL Scoring System (ICSS) in 420 Patients with Chronic Lymphocytic Leukemia
47. BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome.
48. Patients with Chronic Lymphocytic Leukemia Carrying t(14;19) Display a Distinctive Transcriptomic Profile and Adverse Outcome, Which Might be Overcome Continuous Therapy with BTK Inhibitors. an Italian Campus CLL and Eric Study
49. Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalities
50. Non-Small Cell Lung Cancer in a Very Young Woman: A Case Report and Critical Review of the Literature
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.